Trial Profile
Cohort study of infectious disease risk management in Rheumatoid Arthritis patients receiving tocilizumab
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2012
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ACT4U
- 14 Sep 2012 New trial record